ADNARIA Trademark

Trademark Overview

On Friday, February 12, 2016, a trademark application was filed for ADNARIA with the United States Patent and Trademark Office. The USPTO has given the ADNARIA trademark a serial number of 86906672. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 25, 2019. This trademark is owned by Clovis Oncology, Inc.. The ADNARIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
adnaria

General Information

Serial Number86906672
Word MarkADNARIA
Filing DateFriday, February 12, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 19, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameClovis Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameClovis Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events

Event DateEvent Description
Monday, February 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, June 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 13, 2018EXTENSION 4 GRANTED
Wednesday, June 13, 2018EXTENSION 4 FILED
Wednesday, June 13, 2018TEAS EXTENSION RECEIVED
Thursday, December 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2017EXTENSION 3 GRANTED
Tuesday, December 12, 2017EXTENSION 3 FILED
Tuesday, December 12, 2017TEAS EXTENSION RECEIVED
Tuesday, June 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 16, 2017EXTENSION 2 GRANTED
Friday, June 16, 2017EXTENSION 2 FILED
Friday, June 16, 2017TEAS EXTENSION RECEIVED
Friday, January 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2017EXTENSION 1 GRANTED
Wednesday, January 11, 2017EXTENSION 1 FILED
Wednesday, January 11, 2017TEAS EXTENSION RECEIVED
Tuesday, July 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, April 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, April 10, 2016ASSIGNED TO EXAMINER
Friday, February 19, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 16, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

adnaria cancer treatment preparations pharmaceutical